GoodRx(GDRX)

Search documents
GoodRx(GDRX) - 2021 Q3 - Earnings Call Presentation
2021-11-12 20:55
Q3 2021 Letter to Shareholders November 10, 2021 GoodRx helps Americans get the healthcare they need at a price they can afford. I use GoodRx myself because I have a high deductible insurance plan. Paying $100 for a medication is ridiculous even for a doctor. Alysia Ogburia, MD Primary Care Physician GoodRx Holdings, Inc. Q3 2021 Letter to Shareholders 2 Perspectives from Doug and Trevor | --- | --- | |---------------------------------------------------------------------------------------------------------- ...
GoodRx(GDRX) - 2021 Q3 - Quarterly Report
2021-11-11 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39549 GoodRx Holdings, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 47-5104396 (State or other jurisd ...
GoodRx(GDRX) - 2021 Q3 - Earnings Call Transcript
2021-11-11 02:06
Goodrx Holdings, Inc. (NASDAQ:GDRX) Q3 2021 Earnings Conference Call November 10, 2021 5:00 PM ET Company Participants Whitney Notaro - VP, IR Douglas Hirsch - Co-CEO & Director Trevor Bezdek - Co-CEO, Secretary & Director Karsten Voermann - CFO Conference Call Participants Jailendra Singh - Crédit Suisse Sean Dodge - RBC Capital Markets Stephanie Davis - SVB Leerink John Ransom - Raymond James & Associates George Hill - Deutsche Bank Douglas Anmuth - JPMorgan Chase & Co. Vikram Kesavabhotla - Robert W. Bai ...
GoodRx(GDRX) - 2021 Q2 - Earnings Call Transcript
2021-08-12 22:31
GoodRx Holdings, Inc. (NASDAQ:GDRX) Q2 2021 Earnings Conference Call August 12, 2021 8:00 AM ET Company Participants Whitney Notaro – Vice President-Investor Relations Trevor Bezdek – Co-Founder and Co-Chief Executive Officer Doug Hirsch – Co-Founder and Co-Chief Executive Officer Bansi Nagji – President-Healthcare Karsten Voermann – Chief Financial Officer Conference Call Participants Stephanie Davis – SVB Leerink Mark Mahaney – Evercore ISI Charles Rhyee – Cowen Ross Sandler – Barclays Justin Post – Bank ...
GoodRx(GDRX) - 2021 Q2 - Earnings Call Presentation
2021-08-12 19:12
GoodR Q2 2021 Earnings Call Featuring Pharma Manufacturer Solutions August 12, 2021 Disclaimer This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this presentation that do not relate to matters of historical fact should be considered forward-looking statements, including without limitation statements regarding our future operations and financial results, the underlying trends in our business, our marke ...
GoodRx(GDRX) - 2021 Q2 - Quarterly Report
2021-08-11 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39549 GoodRx Holdings, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 47-5104396 (State or other jurisdictio ...
GoodRx Holdings (GDRX) Investor Presentation - Slideshow
2021-05-21 19:53
| --- | --- | --- | --- | --- | |------------------------------------------|--------------|--------------------|-------|---------| | | | | | | | | | | | | | | | | | | | Building theLeading Digital Platform for | Building the | Digital Healthcare | | Largest | | Consumer Healthcare May 2021 | MARCH 2020 | Marketplace | | | | | | | | | Disclaimer This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this pr ...
GoodRx(GDRX) - 2021 Q1 - Earnings Call Presentation
2021-05-14 16:44
| --- | --- | --- | --- | --- | |------------------------------------------|--------------|--------------------|-------|---------| | | | | | | | | | | | | | | | | | | | Building theLeading Digital Platform for | Building the | Digital Healthcare | | Largest | | Consumer Healthcare May 2021 | MARCH 2020 | Marketplace | | | | | | | | | Disclaimer This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this pr ...
GoodRx(GDRX) - 2021 Q1 - Earnings Call Transcript
2021-05-14 05:52
GoodRx Holdings, Inc. (NASDAQ:GDRX) Q1 2021 Earnings Conference Call May 13, 2021 5:00 PM ET Company Participants Whitney Notaro - Vice President, Investor Relations Doug Hirsch - Co-Founder and Co-Chief Executive Officer Trevor Bezdek - Co-Founder and Co-Chief Executive Officer Karsten Voermann - Chief Financial Officer Conference Call Participants Ricky Goldwasser - Morgan Stanley Steven Valiquette - Barclays Jian Li - Evercore ISI Sean Dodge - RBC Capital Stephanie Davis - SVB Leerink Charles Rhyee - Cow ...
GoodRx(GDRX) - 2021 Q1 - Quarterly Report
2021-05-13 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39549 GoodRx Holdings, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 47-5104396 (State or other jurisdicti ...